Beijing Beilu Pharmaceutical Hits Day High with 20% Surge in Stock Price

Beijing Beilu Pharmaceutical Co., Ltd. has experienced significant activity today, with the stock surging by 20.0% on August 21, 2026. The stock reached an intraday high of CNY 10.44, reflecting strong performance metrics in the pharmaceuticals and biotechnology sector. In terms of performance, Beijing Beilu has outpaced the China Shanghai Composite index, which saw a modest increase of 0.04% on the same day. Over the past week, the stock has risen by 19.59%, and its one-month performance stands at an impressive 38.65%. Year-to-date, the stock has gained 31.49%, contrasting with the composite index's decline of 1.6%. Financially, the company reported a robust operating profit growth of 24.59% and has shown consistent positive results over the last five quarters. Key metrics include a net sales figure of CNY 652.96 million, reflecting a growth rate of 21.7%, and a return on capital employed (ROCE) of 6.18%. With a market capitalization of CNY 3,481 million, Beijing Beilu continues to demonstrate resilience and growth potential within its industry.